# Mammoth Biosciences wins DARPA subcontract for CRISPR diagnostics

Mammoth Biosciences secured a subcontract with MRIGlobal for the DARPA DIGET program to develop CRISPR-based diagnostics and biosurveillance platforms for the U.S. Department of Defense.

- Type: Contract
- Announced: 2021-01-14
- Where: United States
- Status: announced
- Products: CRISPR-based diagnostics platforms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Mammoth Biosciences](https://endata.com/companies/52532.md)
- [DARPA](https://endata.com/companies/34950.md) (customer)
- [MRIGlobal](https://endata.com/companies/52533.md) (partner)

## Sources

- [webwire.com](https://www.webwire.com/ViewPressRel.asp?aId=269000), 2021-01-14: "Mammoth Biosciences, Inc. today announced that it has secured a subcontract with MRIGlobal, the prime contractor with the Defense Advanced Research Projects Agency (DARPA), to develop CRISPR-based diagnostics and biosurveillance technologies for the U.S. Department of Defense."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.